Philippe Clezardin

Faculty Of Medicine Lyon Est
Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 128 publications

Dissociated skeletal response to first-line immunotherapy in synchronous bone metastatic non-small cell lung cancer patients: Clinical profiles and survival benefit of denosumab adjunction.

Dissociated skeletal response to first-line immunotherapy in synchronous bone metastatic non-small cell lung cancer patients: Clinical profiles and survival benefit of denosumab adjunction.

Journal: Journal of bone oncology

Published: July 08, 2026

Chromatin Engagement and Transcriptional Activity of the ZNF217 Exon 4-Skipping Isoform Are Associated with Breast Cancer Aggressiveness and Bone Metastasis.

Chromatin Engagement and Transcriptional Activity of the ZNF217 Exon 4-Skipping Isoform Are Associated with Breast Cancer Aggressiveness and Bone Metastasis.

Journal: Cancers

Published: December 30, 2025

Contribution of the immune bone marrow microenvironment to tumor growth and bone deconstruction: implications for improving immunotherapeutic strategies in bone metastasis.

Contribution of the immune bone marrow microenvironment to tumor growth and bone deconstruction: implications for improving immunotherapeutic strategies in bone metastasis.

Journal: Neoplasia (New York, N.Y.)

Published: July 28, 2025

Synergistic effect between denosumab and immune checkpoint inhibitors (ICI)? A retrospective study of 268 patients with ICI and bone metastases.

Synergistic effect between denosumab and immune checkpoint inhibitors (ICI)? A retrospective study of 268 patients with ICI and bone metastases.

Journal: Journal of bone oncology

Published: July 26, 2024

Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative Rhabdomyosarcoma.

Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative Rhabdomyosarcoma.

Journal: Cancers

Published: February 16, 2024

Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis.

Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis.

Journal: Breast cancer research : BCR

Published: October 27, 2023

LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer.

LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer.

Journal: Journal of bone oncology

Published: May 16, 2023

Liposome-encapsulated zoledronate increases inflammatory macrophage population in TNBC tumours.

Liposome-encapsulated zoledronate increases inflammatory macrophage population in TNBC tumours.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: March 08, 2023

The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression.

The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression.

Journal: Cancers

Published: October 27, 2022

MiRNAs and snoRNAs in Bone Metastasis: Functional Roles and Clinical Potential.

MiRNAs and snoRNAs in Bone Metastasis: Functional Roles and Clinical Potential.

Journal: Cancers

Published: October 26, 2022

MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness.

MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness.

Journal: British journal of cancer

Published: September 28, 2022

NALCN-mediated sodium influx confers metastatic prostate cancer cell invasiveness.

NALCN-mediated sodium influx confers metastatic prostate cancer cell invasiveness.

Journal: The EMBO journal

Published: July 23, 2022

Showing 1-12 of 128

Last Updated: 09/26/2026